BioSig Technologies, Inc.
BSGM
$0.736
-$0.0016-0.22%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 180.00% | -91.11% | -99.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 180.00% | -91.11% | -99.26% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 180.00% | -88.89% | -99.05% |
| SG&A Expenses | -1.85% | -46.04% | -53.85% | -16.82% | -41.03% |
| Depreciation & Amortization | -66.30% | -46.74% | -7.14% | 12.05% | 9.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.20% | -51.37% | -56.73% | -13.37% | -38.80% |
| Operating Income | 27.18% | 51.49% | 56.89% | 11.87% | 37.54% |
| Income Before Tax | 52.74% | 64.86% | 53.74% | 12.41% | 37.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.74% | 64.86% | 53.74% | 12.41% | 37.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -110.81% | -74.00% | 107.89% | -557.52% |
| Net Income | 58.09% | 64.71% | 53.60% | 13.06% | 28.33% |
| EBIT | 27.18% | 51.49% | 56.89% | 11.87% | 37.54% |
| EBITDA | 26.27% | 51.53% | 57.46% | 12.16% | 38.16% |
| EPS Basic | 80.25% | 80.79% | 69.73% | 49.21% | 57.30% |
| Normalized Basic EPS | 72.01% | 73.93% | 73.00% | 48.82% | 53.80% |
| EPS Diluted | 80.25% | 80.79% | 69.73% | 49.21% | 57.30% |
| Normalized Diluted EPS | 72.01% | 73.93% | 73.00% | 48.82% | 53.80% |
| Average Basic Shares Outstanding | 114.95% | 83.78% | 59.31% | 69.09% | 67.43% |
| Average Diluted Shares Outstanding | 114.95% | 83.78% | 59.31% | 69.09% | 67.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
